文献速递静脉血栓栓塞慢性静脉疾病外周动脉疾病

血管外科术后血栓预防作用随机对照试验的系统评价与Meta分析

Meta-analysis and systematic review of randomized controlled trials assessing the role of thromboprophylaxis after vascular surgery.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-09-08

与安慰剂相比,抗凝治疗与深静脉血栓(DVT)和肺栓塞(PE)发生减少的趋势相关,但未达统计学显著性;出血结局在两组间无差异。

要点

  • 血管外科术后抗凝预防血栓可能降低DVT与PE风险,但差异未达统计学显著。
  • 抗凝治疗与安慰剂的出血结局无显著差异。
  • 低分子肝素与普通肝素直接比较未见结局显著差异。

核心结论

  • 血管外科患者抗凝血栓预防较安慰剂显示VTE发生率降低趋势,但差异无统计学显著性,出血结局相当。

主要发现

  • 与安慰剂相比,抗凝与DVT风险比RR 0.34(95%CI 0.11-1.05,P=.06,I2=68%)及PE风险比RR 0.17(95%CI 0.02-1.22,P=.08,I2=41%)相关,但均未达统计学显著。
  • 抗凝与安慰剂出血结局比较RR 0.90(95%CI 0.05-15.01,P=.94,I2=76%)。
  • 低分子肝素与普通肝素直接比较未见显著差异。
  • 敏感性分析中,抗凝与静脉手术患者DVT或PE显著减少相关,而动脉手术患者未见显著减少,但各组研究数少。

临床怎么用

  • 现有证据不足以支持血管外科术后常规抗凝预防可显著减少VTE,临床决策需权衡血栓与出血风险。

局限性

  • 各亚组研究数量少,敏感性分析受限;DVT、PE及出血结局的异质性较高(I2分别为68%、41%、76%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a well-known complication associated with surgical procedures. The implementation of thromboprophylaxis in this population has become a vital aspect of perioperative care to decrease VTE-associated morbidity and mortality risk. However, data assessing the role of thromboprophylaxis for patients undergoing vascular surgery are sparse. Assessing the role of thromboprophylaxis by low-molecular-weight heparin or unfractionated heparin in vascular surgery. METHODS: We searched MEDLINE, Embase, and the Cochrane Collaboration Central Register of Controlled Trials from inception until December 2020, for randomized controlled trials assessing the role of thromboprophylaxis in vascular surgery. RESULTS: Eight randomized controlled trials met inclusion criteria, including 3130 patients, with a mean age of 55.35 years and 45% were females. Compared with placebo, anticoagulant use was associated with a decrease in deep venous thrombosis (DVT) (risk ratio [RR], 0.34; 95% confidence interval [CI], 0.11-1.05; P = .06; I2 = 68%) and pulmonary embolism (PE) (RR, 0.17; 95% CI, 0.02-1.22; P = .08; I2 = 41%), but this trend did not attain statistical significance. There was no difference for bleeding outcomes between anticoagulants and placebo (RR, 0.90; 95% CI, 0.05-15.01; P = .94; I2 = 76%). There was no significant difference in outcomes when low-molecular-weight heparin was compared directly with unfractionated heparin. In a sensitivity analysis, anticoagulant use was associated with a significant decrease in DVT or PE in patients undergoing venous surgeries, but was not associated with a significant decrease in DVT or PE in patients undergoing arterial surgeries, although this analysis was limited by the small number of studies in each group. CONCLUSIONS: Among patients undergoing vascular surgery, thromboprophylaxis with anticoagulants showed a trend toward a lesser incidence of VTE when compared with placebo, although this difference was not statistically significant. Bleeding outcomes were comparable between both treatment groups.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Haykal T, Zayed Y, Kerbage J, et al. Meta-analysis and systematic review of randomized controlled trials assessing the role of thromboprophylaxis after vascular surgery. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34508872. doi:10.1016/j.jvsv.2021.08.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。